NCT03300492: Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 10 planned
- Started
- 12 Nov 2018
- Primary completion
- 31 Dec 2026
- Arms
- NK-DLI
- Results
- None posted
- 3 Oct 2017: Trial registered
- 12 Nov 2018: Trial started